Capture of viable circulating tumor cells in the liver of colorectal cancer patients

Clinical Chemistry

Volumn 59, Issue 9, 2013, Pages 1384-1392

  Denève, Eric ^a   Riethdorf, Sabine ^b   Ramos, Jeanne ^c   Nocca, David ^a   Coffy, Amandine ^d   Daurès, Jean Pierre ^d   Maudelonde, Thierry ^a   Fabre, Jean Michel ^a   Pantel, Klaus ^b   Alix Panabières, Catherine ^a,d  

^a HÔPITAL SAINT ELOI   (France)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c GUI DE CHAULIAC HOSPITAL   (France)

^d UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 19; EPITHELIAL CELL ADHESION MOLECULE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER CELL; CANCER PROGNOSIS; CELL ASSAY; CELL VIABILITY; CELLSEARCH ASSAY; CIRCULATING TUMOR CELL; COLORECTAL CANCER; CONTROLLED STUDY; EPISPOT ASSAY; FEMALE; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LIVER; MAJOR CLINICAL STUDY; MALE; MESENTERY; METASTASIS; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; COLON; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER; MALE; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; RECTUM;

EID: 84883375246     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2013.202846     Document Type: Article

References (40)

1. Alix-Panabières C, Schwarzenbach H, Pantel K. Circulating tumor cells and circulating tumor DNA. Annu Rev Med 2012;63:199 -215.
2. Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer 2004;4:448 -56.
3. Pantel K. Circulating tumour cells in cancer patients: challenges and perspectives. Trends Mol Med 2010;16:398-406.
4. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004;351:781-91.
5. Riethdorf S, Fritsche H, Mueller V, Rau T, Schindlbeck C, Rack B, et al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res 2007;13: 920-8.
6. Cohen SJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 2008; 26:3213-21.
7. Gires O, Bauerle PA. EpCAM as a target in cancer therapy. J Clin Oncol 2010;28:e239-40; author reply e41-2.
8. Zöeller M, Thorsten J. The colorectal cancer initiating cell: markers and their role in liver metastases. In: Brodt P, ed. Liver metastasis: biology and clinical management. Canada: Springer, 2011; p. 89-111.
9. Rossi E, Basso U, Celadin R, Zilio F, Pucciarelli S, Aieta M, et al. M30 neoepitope expression in epithelial cancer: quantification of apoptosis in circulating tumor cells by CellSearch analysis. Clin Cancer Res 2010;16:5233- 43.
10. Alix-Panabieres C, Vendrell JP, Slijper M, Pelle O, Barbotte E, Mercier G, et al. Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer. Breast Cancer Res 2009;11:R39.
11. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002;2:563-72.
12. Wind J, Tuynman JB, Tibbe AG, Swennenhuis JF, Richel DJ, van Berge Henegouwen MI, Bemelman WA. Circulating tumour cells during laparoscopic and open surgery for primary colonic cancer in portal and peripheral blood. Eur J Surg Oncol 2009;35:942-50.
13. Rahbari NN, Bork U, Kircher A, Nimitz T, Scholch S, Kahlert C, et al. Compartmental differences of circulating tumor cells in colorectal cancer. Ann Surg Oncol 2012;19:2195-202.
14. Schwarzenbach H, Alix-Panabieres C, Muller I, Letang N, Vendrell JP, Rebillard X, Pantel K. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer. Clin Cancer Res 2009;15:1032- 8.
15. Jiao LR, Apostolopoulos C, Jacob J, Szydlo R, Johnson N, Tsim N, et al. Unique localization of circulating tumor cells in patients with hepatic metastases. J Clin Oncol 2009;27:6160 -5.
16. Thorsteinsson M, Soletormos G, Jess P. Low number of detectable circulating tumor cells in non-metastatic colon cancer. Anticancer Res 2011;31: 613-7.
17. Pantel K, Deneve E, Nocca D, Coffy A, Vendrell JP, Maudelonde T, et al. Circulating epithelial cells in patients with benign colon diseases. Clin Chem 2012;58:936-40.
18. Gasch C, Bauernhofer T, Pichler M, Langer-Freitag S, Reeh M, Seifert AM, et al. Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer. Clin Chem 2013;59:252- 60.
19. Konopke R, Distler M, Ludwig S, Kersting S. Location of liver metastases reflects the site of the primary colorectal carcinoma. Scand J Gastroenterol 2008;43:192-5.
20. Sadahiro S, Suzuki T, Tokunaga N, Yurimoto S, Yasuda S, Tajima T, et al. Detection of tumor cells in the portal and peripheral blood of patients with colorectal carcinoma using competitive reverse transcriptase-polymerase chain reaction. Cancer 2001;92:1251- 8.
21. Bidard FC, Ferrand FR, Huguet F, Hammel P, Louvet C, Malka D, et al. Disseminated and circulating tumor cells in gastrointestinal oncology. Crit Rev Oncol Hematol 2012;82:103-15.
22. Thalheimer A, Otto C, Bueter M, Illert B, Gattenlohner S, Gasser M, et al. Tumor cell dissemination in a human colon cancer animal model: orthotopic implantation or intraportal injection? Eur Surg Res 2009;42:195-200.
23. Uhr JW, Pantel K. Controversies in clinical cancer dormancy. Proc Natl Acad Sci U S A 2011;108: 12396-400.
24. Koch M, Kienle P, Logan E, Antolovic D, Galindo L, Schmitz-Winnenthal FH, et al. Detection of disseminated tumor cells in liver biopsies of colorectal cancer patients is not associated with a worse prognosis. Ann Surg Oncol 2007;14: 810-7.
25. Katsuno H, Zacharakis E, Aziz O, Rao C, Deeba S, Paraskeva P, et al. Does the presence of circulating tumor cells in the venous drainage of curative colorectal cancer resections determine prognosis? A meta-analysis. Ann Surg Oncol 2008;15:3083-91.
26. Gires O. EpCAM expression on colon cancer metastasis. In: Gires O, Selijer B, eds. Tumor-associated antigens: identification, characterization and clinical applications. Weinheim, Germany: Wiley-Blackwell, 2009.
27. Cimino A, Halushka M, Illei P, Wu X, Sukumar S, Argani P. Epithelial cell adhesion molecule (EpCAM) is overexpressed in breast cancer metastases. Breast Cancer Res Treat 2010;123: 701-8.
28. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008;8:755-68.
29. Dieter SM, Ball CR, Hoffmann CM, Nowrouzi A, Herbst F, Zavidij O, et al. Distinct types of tumor-initiating cells form human colon cancer tumors and metastases. Cell Stem Cell 2011;9: 357- 65.
30. Vidal-Vanaclocha F. The liver prometastatic reaction of cancer patients: implications for microenvironment-dependent colon cancer gene regulation. Cancer Microenviron 2011;4:163- 80.
31. Barbera-Guillem E, Weiss L. Cancer-cell traffic in the liver. III. Lethal deformation of B16 melanoma cells in liver sinusoids. Int J Cancer 1993;54: 880-4.
32. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008;134:1655- 69.
33. Jungermann K. Functional heterogeneity of periportal and perivenous hepatocytes. Enzyme 1986; 35:161- 80.
34. Parker GA, Picut CA. Liver immunobiology. Toxicol Pathol 2005;33:52- 62.
35. Cohen SJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, et al. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann Oncol 2009;20: 1223-9.
36. Sastre J, Maestro ML, Puente J, Veganzones S, Alfonso R, Rafael S, et al. Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables. Ann Oncol 2008;19: 935-8.
37. Tol J, Koopman M, Miller MC, Tibbe A, Cats A, Creemers GJ, et al. Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents. Ann Oncol 2010;21:1006 -12.
38. Sergeant G, Penninckx F, Topal B. Quantitative RT-PCR detection of colorectal tumor cells in peripheral blood: a systematic review. J Surg Res 2008;150:144 -52.
39. Rahbari NN, Aigner M, Thorlund K, Mollberg N, Motschall E, Jensen K, et al. Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterology 2010;138:1714 -26.
40. Riethmuller G, Holz E, Schlimok G, Schmiegel W, Raab R, Hoffken K, et al. Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial. J Clin Oncol 1998;16:1788 -94.